156 related articles for article (PubMed ID: 11499867)
1. Accelerated turnover of metaphyseal trabecular bone in mice overexpressing cathepsin K.
Kiviranta R; Morko J; Uusitalo H; Aro HT; Vuorio E; Rantakokko J
J Bone Miner Res; 2001 Aug; 16(8):1444-52. PubMed ID: 11499867
[TBL] [Abstract][Full Text] [Related]
2. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.
Kiviranta R; Morko J; Alatalo SL; NicAmhlaoibh R; Risteli J; Laitala-Leinonen T; Vuorio E
Bone; 2005 Jan; 36(1):159-72. PubMed ID: 15664014
[TBL] [Abstract][Full Text] [Related]
3. Expression profiles of mRNAs for osteoblast and osteoclast proteins as indicators of bone loss in mouse immobilization osteopenia model.
Rantakokko J; Uusitalo H; Jämsä T; Tuukkanen J; Aro HT; Vuorio E
J Bone Miner Res; 1999 Nov; 14(11):1934-42. PubMed ID: 10571694
[TBL] [Abstract][Full Text] [Related]
4. Differential turnover of cortical and trabecular bone in transgenic mice overexpressing cathepsin K.
Morko J; Kiviranta R; Hurme S; Rantakokko J; Vuorio E
Bone; 2005 May; 36(5):854-65. PubMed ID: 15826870
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of cathepsin K accelerates the resorption cycle and osteoblast differentiation in vitro.
Morko J; Kiviranta R; Mulari MT; Ivaska KK; Väänänen HK; Vuorio E; Laitala-Leinonen T
Bone; 2009 Apr; 44(4):717-28. PubMed ID: 19118660
[TBL] [Abstract][Full Text] [Related]
6. Osteoclast polarization is not required for degradation of bone matrix in rachitic FGF23 transgenic mice.
Hollberg K; Marsell R; Norgård M; Larsson T; Jonsson KB; Andersson G
Bone; 2008 Jun; 42(6):1111-21. PubMed ID: 18346951
[TBL] [Abstract][Full Text] [Related]
7. Transgenic mice overexpressing macrophage migration inhibitory factor (MIF) exhibit high-turnover osteoporosis.
Onodera S; Sasaki S; Ohshima S; Amizuka N; Li M; Udagawa N; Irie K; Nishihira J; Koyama Y; Shiraishi A; Tohyama H; Yasuda K
J Bone Miner Res; 2006 Jun; 21(6):876-85. PubMed ID: 16753018
[TBL] [Abstract][Full Text] [Related]
8. Cathepsin K deficiency partially inhibits, but does not prevent, bone destruction in human tumor necrosis factor-transgenic mice.
Schurigt U; Hummel KM; Petrow PK; Gajda M; Stöckigt R; Middel P; Zwerina J; Janik T; Bernhardt R; Schüler S; Scharnweber D; Beckmann F; Saftig P; Kollias G; Schett G; Wiederanders B; Bräuer R
Arthritis Rheum; 2008 Feb; 58(2):422-34. PubMed ID: 18240253
[TBL] [Abstract][Full Text] [Related]
9. Effects of antisense mediated inhibition of cathepsin K on human osteoclasts obtained from peripheral blood.
Avnet S; Lamolinara A; Zini N; Solimando L; Quacquaruccio G; Granchi D; Maraldi NM; Giunti A; Baldini N
J Orthop Res; 2006 Aug; 24(8):1699-708. PubMed ID: 16795033
[TBL] [Abstract][Full Text] [Related]
10. Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: differences between calvaria and long bone.
Everts V; Korper W; Hoeben KA; Jansen ID; Bromme D; Cleutjens KB; Heeneman S; Peters C; Reinheckel T; Saftig P; Beertsen W
J Bone Miner Res; 2006 Sep; 21(9):1399-408. PubMed ID: 16939398
[TBL] [Abstract][Full Text] [Related]
11. Female estrogen receptor beta-/- mice are partially protected against age-related trabecular bone loss.
Windahl SH; Hollberg K; Vidal O; Gustafsson JA; Ohlsson C; Andersson G
J Bone Miner Res; 2001 Aug; 16(8):1388-98. PubMed ID: 11499861
[TBL] [Abstract][Full Text] [Related]
12. Targeted overexpression of G protein-coupled receptor kinase-2 in osteoblasts promotes bone loss.
Wang L; Liu S; Quarles LD; Spurney RF
Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E826-34. PubMed ID: 15585587
[TBL] [Abstract][Full Text] [Related]
13. The anabolic action of intermittent PTH in combination with cathepsin K inhibitor or alendronate differs depending on the remodeling status in bone in ovariectomized mice.
Yamane H; Sakai A; Mori T; Tanaka S; Moridera K; Nakamura T
Bone; 2009 Jun; 44(6):1055-62. PubMed ID: 19303837
[TBL] [Abstract][Full Text] [Related]
14. Transgenic mice with osteoblast-targeted insulin-like growth factor-I show increased bone remodeling.
Jiang J; Lichtler AC; Gronowicz GA; Adams DJ; Clark SH; Rosen CJ; Kream BE
Bone; 2006 Sep; 39(3):494-504. PubMed ID: 16644298
[TBL] [Abstract][Full Text] [Related]
15. Targeted expression of calcitonin gene-related peptide to osteoblasts increases bone density in mice.
Ballica R; Valentijn K; Khachatryan A; Guerder S; Kapadia S; Gundberg C; Gilligan J; Flavell RA; Vignery A
J Bone Miner Res; 1999 Jul; 14(7):1067-74. PubMed ID: 10404006
[TBL] [Abstract][Full Text] [Related]
16. Unmasking the osteoinductive effects of a G-protein-coupled receptor (GPCR) kinase (GRK) inhibitor by treatment with PTH(1-34).
Wang L; Quarles LD; Spurney RF
J Bone Miner Res; 2004 Oct; 19(10):1661-70. PubMed ID: 15355561
[TBL] [Abstract][Full Text] [Related]
17. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation.
Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y
J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673
[TBL] [Abstract][Full Text] [Related]
18. Bone density, strength, and formation in adult cathepsin K (-/-) mice.
Pennypacker B; Shea M; Liu Q; Masarachia P; Saftig P; Rodan S; Rodan G; Kimmel D
Bone; 2009 Feb; 44(2):199-207. PubMed ID: 18845279
[TBL] [Abstract][Full Text] [Related]
19. Characterization of mouse cathepsin K gene, the gene promoter, and the gene expression.
Li YP; Chen W
J Bone Miner Res; 1999 Apr; 14(4):487-99. PubMed ID: 10234569
[TBL] [Abstract][Full Text] [Related]
20. Human osteoblasts produce cathepsin K.
Mandelin J; Hukkanen M; Li TF; Korhonen M; Liljeström M; Sillat T; Hanemaaijer R; Salo J; Santavirta S; Konttinen YT
Bone; 2006 Jun; 38(6):769-77. PubMed ID: 16337236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
